biomarker-investigation-zhcn

You can search a disease, drug, or target to retrieve and validate biomarker evidence across patents, papers, and clinical trials, distinguishing diagnostic, prognostic, predictive, and pharmacodynamic roles.

Diagnostic biomarkers identify disease presence, predictive biomarkers forecast treatment response, and pharmacodynamic biomarkers show drug activity, all classified through evidence retrieval from clinical trials and literature.

Assess biomarker patent risk by searching patent records to identify existing biomarker claims and evaluate potential freedom-to-operate concerns for your R&D program.

Yes, you can search using precise target and clinical indication queries to retrieve biomarker evidence across biomedical intelligence sources including literature, drug records, and clinical trials.

Yes, the tool summarizes biomarker evidence, patent landscape, and clinical relevance in Chinese after performing entity-driven retrieval and fetch-after-search validation from MCP data sources.

Limitations include the requirement for precise entity-driven retrieval and fetch-after-search validation, as broad queries may return insufficient evidence without proper biomarker link validation across patents and literature.